Galectin Therapeutics Inc (GALT)

CIK 1133416 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Galectin Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Oct 13, 2026DEF 14A0001140361-26-039379
Oct 13, 2026ARS0001140361-26-039381
Oct 13, 2026DEFA14A0001140361-26-039380
Oct 2, 2026PRE 14A0001140361-26-038402
Aug 14, 20268-K0001140361-26-032946
Aug 14, 202610-Q0001140361-26-032945
Aug 4, 202640001133416-26-000065
Aug 4, 2026SCHEDULE 13D/A0001140361-26-031060
Aug 4, 20268-K0001140361-26-031058
Jul 16, 202640001133416-26-000063
Jun 30, 202640001133416-26-000061
Jun 30, 202640001133416-26-000059
Jun 29, 20261440001628280-26-045997
Jun 26, 20261440001628280-26-045766
Jun 26, 20261440001972481-26-000216
Jun 25, 202640001133416-26-000057
Jun 23, 20268-K0001140361-26-026031
Jun 23, 20261440001972481-26-000208
May 28, 202640001133416-26-000055
May 15, 20268-K0001140361-26-021496
May 15, 202610-Q0001140361-26-021495
Apr 10, 2026EFFECT9999999995-26-001150
Mar 31, 20268-K0001140361-26-012158
Mar 31, 202610-K0001140361-26-012155
Mar 31, 2026S-30001140361-26-012329